Ivan Galanin, founder of Adipeau

Let’s ChatIvan received his scientific training in inflammation research at sanofi. Before he started Adipeau, he founded two successful companies. Plexcera Therapeutics developed a treatment for a rare pediatric genetic disease (Farber Disease). When Ivan started Plexcera, there was only one living patient with Farber. He sold the company to a large public biotech company. After Plexcera, he started MyPersonalTherapeutics, which identified patient-specific drug combinations for colon cancer. The company built genetically complex fruit fly avatars representing individual human cancers and conducted massive clinical studies in the fruit flies. Both companies were spun out of Mount Sinai School of Medicine, where Ivan had worked as Director of Commercial Development. Ivan is now dedicated to researching how the remarkable regenerative powers of the skin can be harnessed to advance facial and whole body fitness. He was recently published in a notable peer reviewed journal, Aesthetic Plastic Surgery. He is also committed to increasing the level of scientific understanding amongst skincare consumers. --- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/supportSupport the Show.Follow The Show On All Socials Using The Tag @skincareanarchy Hosted on Acast. See acast.com/privacy for more information.

There are no comments yet.

Please log in to write the first comment.